StockNews.com Downgrades Rockwell Medical (NASDAQ:RMTI) to Hold

by · The Markets Daily

StockNews.com lowered shares of Rockwell Medical (NASDAQ:RMTI – Free Report) from a buy rating to a hold rating in a research report sent to investors on Friday morning.

Other analysts have also issued reports about the company. Rodman & Renshaw started coverage on Rockwell Medical in a report on Thursday, November 14th. They set a “buy” rating and a $5.00 target price on the stock. HC Wainwright reduced their price objective on shares of Rockwell Medical from $9.00 to $7.00 and set a “buy” rating on the stock in a research note on Monday, November 25th. Finally, RODMAN&RENSHAW upgraded shares of Rockwell Medical to a “strong-buy” rating in a research report on Thursday, November 14th.

Read Our Latest Report on RMTI

Rockwell Medical Trading Up 1.5 %

Shares of NASDAQ:RMTI opened at $2.08 on Friday. The business’s 50 day simple moving average is $2.89 and its 200 day simple moving average is $2.69. Rockwell Medical has a 1 year low of $1.16 and a 1 year high of $5.15. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.41 and a quick ratio of 2.00. The company has a market capitalization of $67.22 million, a P/E ratio of -41.60 and a beta of 1.38.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in RMTI. Renaissance Technologies LLC increased its position in Rockwell Medical by 877.1% during the 2nd quarter. Renaissance Technologies LLC now owns 102,700 shares of the company’s stock worth $181,000 after purchasing an additional 92,189 shares in the last quarter. Armistice Capital LLC increased its holdings in shares of Rockwell Medical by 22.5% during the second quarter. Armistice Capital LLC now owns 3,221,640 shares of the company’s stock worth $5,670,000 after buying an additional 592,000 shares in the last quarter. Beacon Financial Advisory LLC bought a new position in shares of Rockwell Medical in the 3rd quarter valued at $98,000. Concurrent Investment Advisors LLC acquired a new stake in shares of Rockwell Medical during the 3rd quarter valued at $40,000. Finally, Verus Capital Partners LLC acquired a new position in Rockwell Medical in the 3rd quarter worth about $51,000. Institutional investors own 23.31% of the company’s stock.

About Rockwell Medical

(Get Free Report)

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.

See Also